Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 16, 2010
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamineGiacomo Salvadore, Brian R Cornwell, Fabio Sambataro, et al.
Bipolar Disorders|March 10, 2009
Hot and cold cognition in unmedicated depressed subjects with bipolar disorderJonathan P Roiser, Dara M Cannon, Shilpa K Gandhi, et al.
Biological Psychiatry|December 21, 2006
Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid AMitchel A Kling, Salvatore Alesci, Gyorgy Csako, et al.
The International Journal of Neuropsychopharmacology|November 2, 2011
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depressionGiacomo Salvadore, Jan Willem van der Veen, Yan Zhang, et al.
Psychoneuroendocrinology|August 2, 2015
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorderJonathan Savitz, Robert Dantzer, Timothy B Meier, et al.
Translational Psychiatry|July 23, 2023
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorderKasper Recourt, Peter de Boer, Peter van der Ark, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2021
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy StudyRachel Ochs-Ross, Ewa Wajs, Ella J Daly, et al.
CNS Drugs|July 8, 2021
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesRichard L Doty, Vanina Popova, Crystal Wylie, et al.
Translational Psychiatry|July 23, 2021
No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageingJohn J Cole, Alison McColl, Robin Shaw, et al.
Molecular Psychiatry|August 21, 2019
Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disordersGayle M Wittenberg, Annie Stylianou, Yun Zhang, et al.
Pageof 27